Why Protagonist Therapeutics Stock Is Tanking Today
What happened
Shares of Protagonist Therapeutics (NASDAQ:PTGX), a clinical-stage biotechnology company, are plummeting today. As of 2:26 p.m. EDT, the stock price has fallen 62.9% in response to news of a clinical hold from the FDA.
So what
Protagonist…
